tuberculosis: what you need to know! gini orthner rn, bscn tb nurse clinician tb control...
TRANSCRIPT
Tuberculosis: What you need to know!
Gini Orthner RN, BScNTB Nurse Clinician
TB Control Saskatchewan – Regina Office
History of TB in Saskatchewan
Saskatchewan Anti-TB League was founded in 1911 (TB was out of control with nearly 1000 new cases every year and 1-2 deaths each day).
In 1929 Saskatchewan became the first jurisdiction in North America to provide TB treatment at no cost to the patient – it remains this way!
In 1948 Dr. John Orr introduced prophylactic use of antibiotics in the treatment of children under 5 with positive Mantoux tests.
1957 a centralized patient record system was introduced. This database attracted international attention. We continue to use a form of this database – now a computerized version.
Prince Albert Sanitorium closed in 1961.
Fort San closed in 1972.
Saskatoon Sanitorium closed in 1978.
In 1987 the responsibility for TB was transferred from the Anti-TB League to the provincial government.
Directly observed therapy (DOT) was started in 1990.
In 2007 responsibility for TB was transferred to the Saskatoon Health Region.
The Encyclopedia of Saskatchewan
Current TB Control
3 stationary clinics (Saskatoon, Regina, Prince Albert)
Mobile clinics in northern Sask. Staff consists of
4 physicians6 nurses6 administrative support staff4 TB medication workers
Our Partners
General Practitioners/Specialists
First Nations and Inuit Health
First Nations Bands and Staff
Immigration Canada
Correctional Institutions
Communicable Disease Programs
General Public
What is Tuberculosis (TB)
an Acid Fast Bacilli (AFB) known as Mycobacterium Tuberculosis Complex (MTBC)
an airborne organism that most commonly affects the lungs, but can affect any part of the body
Active TB
Active Pulmonary – affects the lungs and connective airways, can be infectious or non-infectious
Active Non–Pulmonary – affects other parts of the body (lymph nodes, CNS, meninges, ocular, pericardial, abdominal, bones/joints, genitourinary, miliary, great vessels, bone marrow), non-infectious
How is TB Spread?
mostly through inhalation of droplet nuclei. (coughing, sneezing, singing, etc)
very rarely through ingestion (mostly in the past with unpasteurized milk)
Active Pulmonary TB Disease
Infectious or non-infectiousInfectious Non-Infectious
Smear positive -isolation x 2 weeks
Smear negative
Culture positive Culture positive
May have an Abnormal CXR
May have an Abnormal CXR
Start Treatment ASAP Start Treatment ASAP
Latent TB Infection (LTBI)
Inactive TB – Infection, NO DiseaseMantoux is positive (> 10mm)CXR is usually normalProphylaxis treatment offered and encouraged
for <15 years old as most susceptible age group
Latent TB Infection (LTBI)
Treatment determined on case by case basis for 15-35 years old
>35 years old encouraged to monitor for top three signs & symptoms of early TB disease as benefits of treatment do not outweigh the risks (i.e. medication induced hepatitis, thrombocytopenia)
Symptoms of TB
Early Signs of TB Cough for more than 1
month Unexplained fever for
more than 1 week Recurring pneumonia
that does not respond to antibiotics
Signs of Advanced TB Night sweats Weight Loss Fatigue Rash
Diagnostic Tests
Sputum and/or other body fluids for AFBMantoux skin test – gold standard for
diagnosing LTBIChest X-rayCT ScansIGRA (Interferon-Gamma Release Assays)
Mantoux Tests
Indicates TB infection only – does not mean person has TB disease
Elicits cellular immune response to PPD antigen, causing a delayed hypersensitivity reaction.
Mantoux Tests
5 units(0.1ml) of Tuberculin (PPD) injected intradermally, 3-4 fingers down from the anticubital space
Mantoux Tests
Measure transverse diameter of induration only (not erythema)
Record in mm
No induration is recorded as 0mm
Interpreting Mantoux Tests
History of BCG is not considered
Significant Reaction if:10mm or greater5mm or greater in contacts to infectious TB,
HIV positive, pre school children
Treatment - Now
1st Line DrugsIsoniazid (INH)Rifampin (RMP)Ethambutol (EMB)Pyrazinamide (PZA)
2nd Line Drugs
• Moxifloxacin
• Levofloxacin
• Amikacin
Other medication used for treatment include: streptomycin, fluoroquinolone, injectable agents (amikacin, kanamycin, capreomycin, ethionamide, clofazamine, para-aminosalicylic acid, cycloserine, PZA, EMB)
Treatment – Active TB (or suspected)
INH and RMP (standard)28 daily doses followed by twice weekly doses
for 8 months Ideal total of 98 doses within 9 month time
frame4 drug therapy if drug resistance suspected
until drug sensitivity results are obtained (2-6 weeks)
Treatment – LTBI
INH and RMP (standard)6 months of twice weekly medication Ideal total of 52 doses within the 6 month time
frame
Treatment in Saskatchewan
All treatment is provided by directly observed therapy (DOT).
WHY? to prevent drug resistance to prevent relapse of TB to ensure treatment completion
Did you know???
1/3 of the world’s population is infected with TB
Canadian Tuberculosis Standards 2007
Prevalence
WORLD9.4 million new cases of active TB in 2008 1.3 million people die each year from TBCANADA 1600 new cases in 2008SASKATCHEWAN 93 new active cases in 2008
WHOPublic Health Agency of Canada
TB in Canada
BC, Ontario and Quebec made up 69% of total cases
Nunavut had the highest rates
PEI reported no cases!
TB in Canada
Foreign born – 62% of cases
Canadian Aboriginal – 21% of cases
Canadian Non Aboriginal – 13% of cases
TB in Saskatchewan - 2009
2 Cases of TB Meningitis
1 death caused by TB – found on autopsy
2 case of multi-drug resistance (INH and RMP)
TB in Saskatchewan
Canadian Aboriginal – 72 cases
Foreign Born – 11 cases
Canadian Non-Aboriginal – 9 cases
Multi-drug resistant (MDR-TB)
TB bacteria resistant to INH and RMP with or without resistance to other first or second line drugs
WHO
MDR-TB World Wide
0.5 million cases of MDR-TB in 2007
27 countries account for 85% of cases (15 countries are in European Regions)
Top 5 countries affected: India, China, Russia, South Africa, Bangladesh
WHO
Extensively Drug Resistant (XDR-TB)
TB bacteria resistant to at least INH and RMP from the first line drugs plus resistance to any fluoroquinolone and at least one of three injectable second line drugs (capreomycin, kanamycin and amikacin)
WHO
Total Drug Resistance
new term used in an article based on a case in Iran
a case of TB that is essentially resistant to all antibiotics known to effectively treat TB
THINK TB!
Assess for symptoms• Cough with sputum for more than 1 month.
• Unexplained fever for more than 1 week.
• Pneumonia not improving with antibiotic treatment.
THINK TB!
Obtain CXR
Obtain sputum (body fluid) for AFB testing. Send to Provincial Lab.
Contact TB Control with questions and for further instructions
“The most common physical finding in pulmonary TB is a…
totally normal examination.”
Canadian TB Standards, 2007